Bimosiamose
CAS: 187269-40-5
Ref. 3D-MHA26940
1mg | A consultar | |
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar |
Información del producto
- (1,1'-Biphenyl)-3-acetic acid, 3',3'''-(1,6-hexanediyl)bis(6'-(alpha-D-mannopyranosyloxy)-
- (Hexane-1,6-diylbis(6'-(alpha-D-mannopyranosyloxy)biphenyl-3',3-diyl))diacetic acid
- 1,6-Bis(3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyloxy)phenyl)hexane
- 3′,3′′′-(1,6-Hexanediyl)bis[6′-(α-<span class="text-smallcaps">D</span>-mannopyranosyloxy)[1,1′-biphenyl]-3-acetic acid
- Tbc 1269
- Unii-97B5Kcw80W
- [1,1′-Biphenyl]-3-acetic acid, 3′,3′′′-(1,6-hexanediyl)bis[6′-(α-<span class="text-smallcaps">D</span>-mannopyranosyloxy)-
Bimosiamose is a metabolite of the biotin-dependent enzyme, methionine adenosyltransferase. It is an activated form of SAMe and has been shown to have beneficial effects in treating patients with metabolic disorders. Bimosiamose also has anti-inflammatory properties and can be used as an adjunct therapy for bowel disease. In vitro studies have shown that bimosiamose inhibits the activity of monoclonal antibodies that bind to the CD20 receptor on hl-60 cells, which causes these cells to die by apoptosis. This compound is also able to inhibit the production of inflammatory cytokines, such as IL-6 and TNF-α, in vitro.
Propiedades químicas
Consulta técnica sobre: 3D-MHA26940 Bimosiamose
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.